financetom
Business
financetom
/
Business
/
IndusInd Bank's deputy CEO Arun Khurana resigns amid accounting blunder
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IndusInd Bank's deputy CEO Arun Khurana resigns amid accounting blunder
May 25, 2025 8:12 PM

MUMBAI/BENGALURU April 28 (Reuters) -

India's IndusInd Bank on Monday announced the

resignation of deputy CEO Arun Khurana, weeks after the private

lender disclosed

accounting lapses

in its derivatives portfolio that triggered a rout in its

shares

.

In light of the recent

accounting issues related to internal derivative trades

, "I having oversight of the Treasury Front office function,

as the whole time director, Deputy CEO and a part of senior

management of the bank, hereby resign, effective immediately,"

Khurana wrote in a letter to IndusInd Bank's board that was

included in a stock market filing.

IndusInd, India's fifth-largest private lender with a

balance sheet of $63 billion,

said on Sunday

it would take a $229.56 million hit to its accounts for the

financial year ended March 31, 2025 because of the incorrect

treatment of derivatives going back several years.

Based on the findings of an external agency's probe,

IndusInd has estimated an impact of 2.27% on its net worth as of

December 2024.

Khurana headed the global markets division of the bank,

which included the derivatives portfolio.

IndusInd shares have fallen nearly 8% since March 10,

when the lender first disclosed the impact on its net worth from

the discrepancies.

Last week, IndusInd named Santosh Kumar as its deputy

CFO. Kumar will head the finance and accounts functions till

IndusInd appoints a full-time CFO.

The Reserve Bank of India had

urged

CEO Sumant Kathpalia and Khurana to step down following the

accounting lapses, as soon as replacements were found and

approved by the central bank, Reuters reported last month.

The bank is due to report earnings for the full

financial year before May 15, but is yet to disclose the date

for the release.

(Reporting by Siddhi Nayak in Mumbai and Ananta Agarwal in

Bengaluru; Editing by Anil D'Silva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US Transportation Secretary Reportedly Aims to Increase Air Traffic Control Hiring
US Transportation Secretary Reportedly Aims to Increase Air Traffic Control Hiring
Feb 28, 2025
06:20 AM EST, 02/28/2025 (MT Newswires) -- US Transportation Secretary Sean Duffy said that the Trump administration will take steps to hire more air traffic controllers and seek billions of dollars to improve the nation's aviation system, multiple media outlets reported Thursday. This comes after several recent safety incidents and flight delays stemming from a persistent staffing shortage. Reuters reported...
Analysis-Beef prices may rise as Canadian ranchers shrink cattle herds, fearing Trump tariffs
Analysis-Beef prices may rise as Canadian ranchers shrink cattle herds, fearing Trump tariffs
Feb 28, 2025
WINNIPEG, Manitoba (Reuters) - Canadian farmer Jon Vaags quit buying beef cattle in November after the election of U.S. President Donald Trump made tariffs on Canadian exports seem like a serious risk.  Now there are more than 1,000 empty spaces on his feedlot, where cattle are fattened on grain before being slaughtered for beef.  We stopped buying feeder cattle altogether,...
Amneal Pharmaceuticals Q4 Adjusted Earnings Fall, Revenue Rises; 2025 Guidance Set
Amneal Pharmaceuticals Q4 Adjusted Earnings Fall, Revenue Rises; 2025 Guidance Set
Feb 28, 2025
06:16 AM EST, 02/28/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) reported Q4 adjusted earnings Friday of $0.12 per diluted share, down from $0.14 a year earlier. Four analysts polled by FactSet expected $0.15. Revenue for the quarter ended Dec. 31 was $730.5 million compared with $617 million a year earlier. Three analysts surveyed by FactSet expected $708.1 million....
Northwest Natural Q4 Adjusted Earnings, Revenue Rise; 2025 Outlook Issued
Northwest Natural Q4 Adjusted Earnings, Revenue Rise; 2025 Outlook Issued
Feb 28, 2025
06:23 AM EST, 02/28/2025 (MT Newswires) -- Northwest Natural ( NWN ) reported Q4 adjusted net income Friday of $1.41 per diluted share, up from $1.21 a year earlier. Analysts polled by FactSet expected $1.42. Operating revenue for the quarter ended Dec. 31 was $370.9 million, up from $355.7 million a year earlier. Three analysts surveyed by FactSet expected $395.1...
Copyright 2023-2026 - www.financetom.com All Rights Reserved